{"database": "lobbying", "table": "lobbying_activities", "rows": [[1330573, "3e3ffc18-583a-4982-b223-37d701556126", "Q4", "THE LENKER GROUP LLC", 400888599, "SHIRE PLC", 2012, "fourth_quarter", "HCR", "User fees, drug shortages, DEA quotas, exclusivity periods, orphan drugs, health care reform implementation, drug innovation and patient access, approval pathways, priority vouchers, ESRD PPS, pharmaceutical and biotech related legislation; issues\nsurrounding ADHD, tax reform, drug importation, eating disorders, orphan drug tax credit, annual fees on orphan drugs, FDASIA implementation, drug compounding", "HOUSE OF REPRESENTATIVES,Natl Institute of Mental Health (NIMH),SENATE", 30000, null, 0, 0, "2013-01-03T13:19:08.300000-05:00"]], "columns": ["id", "filing_uuid", "filing_type", "registrant_name", "registrant_id", "client_name", "filing_year", "filing_period", "issue_code", "specific_issues", "government_entities", "income_amount", "expense_amount", "is_no_activity", "is_termination", "received_date"], "primary_keys": ["id"], "primary_key_values": ["1330573"], "units": {}, "query_ms": 83.6368310265243, "source": "Federal Register API & Regulations.gov API", "source_url": "https://www.federalregister.gov/developers/api/v1", "license": "Public Domain (U.S. Government data)", "license_url": "https://www.regulations.gov/faq"}